Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.34M Sell
225,900
-246,800
-52% -$6.57M 0.02% 858
2025
Q4
$11.8M Buy
472,700
+394,500
+504% +$9.95M 0.04% 394
2025
Q3
$1.99M Sell
78,200
-99,800
-56% -$2.46M 0.01% 1154
2025
Q2
$4.31M Buy
178,000
+116,200
+188% +$2.71M 0.02% 598
2025
Q1
$1.57M Buy
+61,800
New +$1.62M 0.01% 919
2024
Q3
Sell
-65,300
Closed -$1.83M 2960
2024
Q2
$1.83M Buy
+65,300
New +$1.8M 0.01% 773
2024
Q1
Sell
-61,900
Closed -$1.78M 2899
2023
Q4
$1.78M Buy
61,900
+39,200
+173% +$1.19M 0.01% 704
2023
Q3
$752K Buy
22,700
+14,800
+187% +$523K 0.01% 1179
2023
Q2
$289K Buy
7,900
+1,400
+22% +$54.5K ﹤0.01% 1650
2023
Q1
$265K Buy
6,500
+1,500
+30% +$64.8K ﹤0.01% 1790
2022
Q4
$256K Buy
+5,000
New +$240K ﹤0.01% 1816
2022
Q2
Sell
-20,000
Closed -$1.03M 3538
2022
Q1
$1.03M Buy
20,000
+14,200
+245% +$737K 0.01% 996
2021
Q4
$342K Sell
5,800
-31,600
-84% -$1.57M ﹤0.01% 2176
2021
Q3
$1.61M Buy
+37,400
New +$1.66M 0.01% 879
2020
Q3
Sell
-10,435
Closed -$323K 2239
2020
Q2
$323K Sell
10,435
-2,213
-17% -$75.2K 0.01% 957
2020
Q1
$391K Buy
+12,648
New +$431K 0.03% 445
2019
Q4
Sell
-55,230
Closed -$1.88M 1525
2019
Q3
$1.88M Buy
+55,230
New +$2.01M 0.09% 185

Other funds holding PFE

HRT Financial's PFE Position: Q1 2026 in Review

HRT Financial sold out of Pfizer (PFE) in Q1 2026, closing a stake of 664,987 shares — an estimated $17.7M sold.

HRT Financial first reported a position in PFE in Q4 2014 and held it in 25 quarters. The position peaked at $139M in Q1 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • HRT Financial reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 664,987 Pfizer shares in Q1 2026, an estimated $17.7M.
  • HRT Financial first reported a position in Pfizer in Q4 2014 and held it in 25 quarters.
  • HRT Financial's Pfizer position peaked at $139M in Q1 2025.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.